MarketPeel
Insider Trading Intelligence
JF

Jost Fischer

AEON
DIRECTOR · AEON BIOPHARMA, INC. · CIK 0001366841
FILING MIX · LIFETIME100%/0%
BUYS
17
SELLS
0
TOTAL VALUE
$84.5K
COMPANIES
1
ACTIVE SINCE
Jul 2023
HOLDINGS NOW
489,469
AVG SELL PX
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jost Fischer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+100.00%+21.96%-0.02%+21.98%+19.88%
14d3+100.00%+19.65%+0.81%+18.84%+15.37%
30d3+100.00%+51.88%+1.06%+50.82%+50.84%
60d3+100.00%+57.98%+6.41%+51.57%+48.13%
90d3+100.00%+49.02%+8.81%+40.22%+40.19%
180d3+100.00%+75.91%+13.15%+62.76%+64.81%
1y3+100.00%+75.20%+25.79%+49.42%+49.24%
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AEON · 489,469 shares · as of Jun 17, 2026
0122,367244,735367,102489,469202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 17 buys / 0 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
222,684489,469Jun 17, 2026Jun 22, 2026View →
AEON
AEON BIOPHARMA, INC.
PURCHASE
60,000$0.49$29.3K266,785May 21, 2025May 23, 2025View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
308,641308,641May 21, 2025May 23, 2025View →
AEON
AEON BIOPHARMA, INC.
PURCHASE
60,000$0.51$30.4K206,785May 20, 2025May 21, 2025View →
AEON
AEON BIOPHARMA, INC.
PURCHASE
50,000$0.50$24.9K146,785May 19, 2025May 21, 2025View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
96,21096,210Aug 31, 2024Sep 4, 2024View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
36,02196,785Aug 31, 2024Sep 4, 2024View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
16,26016,260Mar 19, 2024Mar 21, 2024View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
58,85158,851Aug 14, 2023Aug 16, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,3532,353Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
35,18935,189Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
13,27413,274Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
19,28619,286Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
19,80019,800Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
21,19812,198Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
6,2896,289Jul 21, 2023Jul 24, 2023View →
AEON
AEON BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
21,97421,974Jul 21, 2023Jul 24, 2023View →
Other insiders · AEON
Loading peer insiders…
About this filer
CIK 0001366841
ROLE
Director
PRIMARY
AEON
COMPANIES
1
ACTIVE SINCE
Jul 2023
MARKETPEEL · /INSIDER/0001366841DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback